跳至主要内容
临床试验/NCT03574064
NCT03574064已完成不适用

Investigation of GLP-2 Mechanism of Action

University of Copenhagen2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2018年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
2
主要终点
N-terminal propeptide of type 1 procollagen (P1NP). At all time points and AUC(0-240 min).

研究概览

简要总结

We will investigate effects of gut hormones on bone remodeling.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women Age above 50 years Postmenopausal Caucasian BMI 18.5 to 28.0 kg/m2.

排除标准

  • Smoking Medication believed to influence study outcome Weight change more than 3 kg whitin the last 3 months Overweight surgery Intestinal surgery Hgb<7,0 mmol/L Decreased renal function

结局指标

主要结局

N-terminal propeptide of type 1 procollagen (P1NP). At all time points and AUC(0-240 min).

时间窗: -10 minutes to 600 minutes

P1NP is a marker of bone formation. Measured in serum.

C-terminal telopeptide (CTX). At all time points and AUC(0-240 min).

时间窗: -10 minutes to 600 minutes

CTX is a marker of bone resorption. Measured in serum.

次要结局

  • Calcium(-10 minutes to 600 minutes)
  • Insulin(-10 minutes to 600 minutes)
  • Glukagon-like peptide-2 (GLP-2)(-10 minutes to 600 minutes)
  • C-peptide(-10 minutes to 600 minutes)
  • PTH(-10 minutes to 600 minutes)
  • Sclerostin(-10 minutes to 600 minutes)
  • PP(-10 minutes to 600 minutes)
  • Glucose(-10 minutes to 600 minutes)
  • Glucose-dependent insulinotropic polypeptide (GIP)(-10 minutes to 600 minutes)
  • Glukagon-like peptide-1 (GLP-1)(-10 minutes to 600 minutes)
  • Glucagon(-10 minutes to 600 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kirsa Skov-Jeppesen

Principal Investigator

University of Copenhagen

研究点 (2)

Loading locations...

相似试验